Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway

Melville, A. R., Donaldson, K., Dale, J. and Ciechomska, A. (2022) Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway. Rheumatology Advances in Practice, 6(1), rkab102. (doi: 10.1093/rap/rkab102) (PMID:35059557) (PMCID:PMC8765789)

Abstract

Objective: The aim was to provide external validation of the Southend GCA probability score (GCAPS) in patients attending a GCA fast-track pathway (GCA FTP) in NHS Lanarkshire. Methods: Consecutive GCA FTP patients between November 2018 and December 2020 underwent GCAPS assessment as part of routine care. GCA diagnoses were supported by US of the cranial and axillary arteries (USS), with or without temporal artery biopsy (TAB), and confirmed at 6 months. Percentages of patients with GCA according to GCAPS risk group, performance of total GCAPS in distinguishing GCA/non-GCA final diagnoses, and test characteristics using different GCAPS binary cut-offs were assessed. Associations between individual GCAPS components and GCA and the value of USS and TAB in the diagnostic process were also explored. Results: Forty-four of 129 patients were diagnosed with GCA, including 0 of 41 GCAPS low-risk patients (GCAPS <9), 3 of 40 medium-risk patients (GCAPS 9–12) and 41 of 48 high-risk patients (GCAPS >12). Overall performance of GCAPS in distinguishing GCA/non-GCA was excellent [area under the receiver operating characteristic curve, 0.976 (95% CI 0.954, 0.999)]. GCAPS cut-off ≥10 had 100.0% sensitivity and 67.1% specificity for GCA. GCAPS cut-off ≥13 had the highest accuracy (91.5%), with 93.2% sensitivity and 90.6% specificity. Several individual GCAPS components were associated with GCA. Sensitivity of USS increased by ascending GCAPS risk group (nil, 33.3% and 90.2%, respectively). TAB was diagnostically useful in cases where USS was inconclusive. Conclusion: This is the first published study to describe application of GCAPS outside the specialist centre where it was developed. Performance of GCAPS as a risk stratification tool was excellent. GCAPS might have additional value for screening GCA FTP referrals and guiding empirical glucocorticoid treatment.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Ciechomska, Dr Anna and Dale, Dr James and Melville, Dr Andrew
• Authors: Melville, A. R., Donaldson, K., Dale, J., and Ciechomska, A.
• College/School: College of Medical Veterinary and Life Sciences > School of Infection & Immunity; College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
• Journal Name: Rheumatology Advances in Practice
• Publisher: Oxford University Press
• ISSN: 2514-1775
• ISSN (Online): 2514-1775
• Published Online: 15 December 2021
• Copyright Holders: Copyright © 2021 The Authors
• First Published: First published in Rheumatology Advances in Practice 6(1): rkab102
• Publisher Policy: Reproduced under a Creative Commons License